Subcutaneous administration of brain natriuretic peptide in experimental heart failure

Journal of the American College of Cardiology

Volumn 36, Issue 5, 2000, Pages 1706-1712

  Chen, Horng H ^a   Grantham, J Aaron ^b   Schirger, John A ^b   Jougasaki, Michihisa ^b   Redfield, Margaret M ^b   Burnett Jr , John C ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; EXPERIMENTAL MODEL; HEART FAILURE; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VASODILATATION;

ANIMALS; DOGS; HEART FAILURE, CONGESTIVE; INJECTIONS, SUBCUTANEOUS; MALE; NATRIURETIC PEPTIDE, BRAIN;

EID: 0034332775     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00911-6     Document Type: Article

References (24)

1. BNP: Pathophysiological and potential therapeutic roles in acute congestive heart failure
2. Effects of the endogenous natriuretic peptide system on ventricular and coronary function in the failing heart
3. A new natriuretic peptide in porcine brain
4. Isolation and identification of a higher molecular weight brain natriuretic peptide in porcine cardiac atrium
5. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
6. Differential activation by atrial and brain natriuretic peptide of two different receptor guanylate cyclase
7. Effects of synthetic atrial natriuretic factor on renal function and renin release
8. Potentiation of the renal actions of canine brain natriuretic peptide by neutral endopeptidase inhibition
9. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor llgands by endopeptidase-24.11
10. Superiority of brain natriuretic peptide as hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
11. Biochemical detection of left-ventricular systolic dysfunction
12. Hemodynamics and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure
13. Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
14. Systemic hemodynamic, neurohumoral and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure
15. Brain natriuretic peptide: Effect on left ventricular filling patterns in healthy subjects
16. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction
17. Atrial natriuretic peptide elevation in congestive heart failure in man
18. Radioimmunoassay for cyclic nucleotidase
19. Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects
20. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure
21. Effects of brain natriuretic peptide on hemodynamics and renal function in dogs
22. The renal action of atrial natriuretic peptide during control of glomerular filtration
23. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure
24. The role of neutral endopeptidase in dogs with evolving congestive heart failure